Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma

Summary:

The uptake of iodide in thyroid epithelial cells is mediated by the sodium/iodide symporter (NIS). The uptake of iodide is of vital importance for thyroid physiology and is a prerequisite for radioiodine therapy in thyroid cancer. Loss of iodide uptake due to diminished expression of the human NIS (hNIS) is frequently observed in metastasized thyroid cancer. So far, no animal model for the study of radioiodine therapy in thyroid cancer has been available. Strategies to restore iodide uptake in thyroid cancer include the exploration of hNIS gene transfer into hNIS defective thyroid cancer. We have performed a stable transfection of hNIS into the hNIS defective follicular thyroid carcinoma cell line FTC133. Stabily transfected colonies exhibited high uptake of Na¹²⁵I, which could be blocked completely with sodiumperchlorate. hNIS transfected FTC133 and non-transfected cell lines injected subcutaneously in nude mice formed tumors after 6 weeks. Iodide uptake in the hNIS transfected tumor was much higher than in non-transfected tumor, but a rapid release of radioactivity from the hNIS transfected tumor was observed. Further studies are necessary to investigate the role of hNIS in relation to other thyroid specific proteins in iodide metabolism in thyroid cancer.

Key words:

Iodide - sodium/iodide symporter - thyroid carcinoma - transfection

References

• 1 Ambesi-Impiombato F S, Parks L A, Coon H G. Culture of hormone-dependent functional epithelial cells from rat thyroids.  Proc Natl Acad Sci USA. 77 3455-3459 1980; 
• 2 Arturi F, Russo D, Schlumberger M, du V J, Caillou B, Vigneri P, Wicker R, Chiefari E, Suarez H G, Filetti S. Iodide symporter gene expression in human thyroid tumors.  J Clin Endocrinol Metab. 83 2493-2496 1998; 
• 3 Behr M, Schmitt T L, Espinoza C R, Loos U. Cloning of a functional promoter of the human sodium/iodide-symporter gene.  Biochem J. 331 359-363 1998; 
• 4 Caillou B, Troalen F, Baudin E, Talbot M, Filetti S, Schlumberger M, Bidart J M. Na⁺/I^- symporter distribution in human thyroid tissues: an immunohistochemical study.  J Clin Endocrinol Metab. 83 4102-4106 1998; 
• 5 Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter.  Nature. 379 458-460 1996; 
• 6 Filetti S, Bidart J M, Arturi F, Caillou B, Russo D, Schlumberger M. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.  Eur J Endocrinol. 141 443-457 1999; 
• 7 Goretzki P E, Frilling A, Simon D, Roeher H D. Growth regulation of normal thyroids and thyroid tumors in man.  Recent Results Cancer Res. 118 48-63 1990; 
• 8 Hundahl S A, Fleming I D, Fremgen A M, Menck H R. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995.  Cancer. 83 2638-2648 1998; 
• 9 Kawaguchi A, Ikeda M, Endo T, Kogai T, Miyazaki A, Onaya T. Transforming growth factor-beta1 suppresses thyrotropin-induced Na⁺/I^- symporter messenger RNA and protein levels in FRTL-5 rat thyroid cells.  Thyroid. 7 789-794 1997; 
• 10 Lazar V, Bidart J M, Caillou B, Mahe C, Lacroix L, Filetti S, Schlumberger M. Expression of the Na⁺/I^- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.  J Clin Endocrinol Metab. 84 3228-3234 1999; 
• 11 Mandell R B, Mandell L Z, Link C JJ. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene.  Cancer Res. 59 661-668 1999; 
• 12 Morris J C, Kim C K, Padilla M L, Mechanick J I. Conversion of non-iodine-concentrating differentiated thyroid carcinoma metastases into iodine-concentrating foci after anticancer chemotherapy.  Thyroid. 7 63-66 1997; 
• 13 Pelikan D M, Lion H L, Hermans J, Goslings B M. The role of radioactive iodine in the treatment of advanced differentiated thyroid carcinoma.  Clin Endocrinol (Oxf ). 47 713-720 1997; 
• 14 Schlumberger M J. Papillary and follicular thyroid carcinoma.  N Engl J Med. 338 297-306 1998; 
• 15 Schmutzler C, Winzer R, Meissner-Weigl J, Kohrle J. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.  Biochem Biophys Res Commun. 240 832-838 1997; 
• 16 Shimura H, Haraguchi K, Miyazaki A, Endo T, Onaya T. Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na⁺/I^- symporter gene.  Endocrinology. 138 4493-4496 1997; 
• 17 Simon D, Kohrle J, Schmutzler C, Mainz K, Reiners C, Roher H D. Redifferentiation therapy of differentiated thyroid carcinoma with retinoic acid: basics and first clinical results.  Exp Clin Endocrinol Diabetes 104 ((Suppl 4)) 13-15 1996; 
• 18 Smanik P A, Liu Q, Furminger T L, Ryu K, Xing S, Mazzaferri E L, Jhiang S M. Cloning of the human sodium iodide symporter.  Biochem Biophys Res Commun. 226 339-345 1996; 
• 19 Smanik P A, Ryu K Y, Theil K S, Mazzaferri E L, Jhiang S M. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter.  Endocrinology. 138 3555-3558 1997; 
• 20 Smit J W, Vielvoye G J, Goslings B M. Embolization for vertebral metastases of follicular thyroid carcinoma.  J Clin Endocrinol Metab. 85 989-994 2000; 
• 21 Spitzweg C, Zhang S, Bergert E R, Castro M R, McIver B, Heufelder A E, Tindall D J, Young C Y, Morris J C. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.  Cancer Res. 59 2136-2141 1999; 
• 22 Tong Q, Ryu K Y, Jhiang S M. Promoter characterization of the rat Na⁺/I^- symporter gene.  Biochem Biophys Res Commun. 239 34-41 1997; 
• 23 Uyttersprot N, Pelgrims N, Carrasco N, Gervy C, Maenhaut C, Dumont J E, Miot F. Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na⁺/I^- symporter mRNAs in dog thyroid.  Mol Cell Endocrinol. 131 195-203 1997; 
• 24 Van Bezooijen R L, Farih-Sips H C, Papapoulos S E, Lowik C W. IL-1alpha, IL-1beta, IL-6, and TNF-alpha steady-state mRNA levels analyzed by reverse transcription-competitive PCR in bone marrow of gonadectomized mice.  J Bone Miner Res. 13 185-194 1998; 
• 25 Venkataraman G M, Yatin M, Marcinek R, Ain K B. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na⁺/I^-symporter gene methylation status.  J Clin Endocrinol Metab. 84 2449-2457 1999;